Immuno-Oncology
CME
Self-Assessment Credit
Genevieve Boland, MD, PhD (she/her/hers)
Vice Chair of Research, Section Head Melanoma/Sarcoma Surgery
Massachusetts General Hospital
Disclosure(s): Ankyra Therapeutics: Advisor (Ongoing), Consultant (Ongoing), Stocks (Ongoing); InterVenn Bioscience: Advisor (Terminated, November 4, 2022), Consultant (Terminated, November 4, 2022), Research Grant (Terminated, November 4, 2022); Iovance Biotherapeutics: Advisor (Ongoing); Merck: Advisor (Ongoing), Consultant (Ongoing); Nektar Therapeutics: Advisor (Terminated, July 1, 2021); Novartis: Advisor (Terminated, November 4, 2022); Olink Proteomics: Research Grant (Ongoing); Palleon Pharmaceuticals: Research Grant (Terminated, November 4, 2022); Teiko Bio: Research Grant (Ongoing)
Presenter: Kelly Olino, MD (she/her/hers) – Yale School of Medicine
Presenter: Maximilian Diehn, MD, PhD – Stanford University
Presenter: Mark Jesus M. Magbanua, PhD (he/him/his) – University of California San Francisco
Panelist: Kelly Olino, MD (she/her/hers) – Yale School of Medicine
Panelist: Maximilian Diehn, MD, PhD – Stanford University